EST
IMVT icon

EA Series Trust’s Immunovant IMVT Stock Holding History

EA Series Trust’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		$2.58M Buy
+136,097
New +$2.54M 0.09% 318

Other funds holding IMVT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
AGM
Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return

EA Series Trust's IMVT Position: Q2 2023 in Review

EA Series Trust opened a new position in Immunovant (IMVT) in Q2 2023: 136,097 shares worth $2.58M. The stake represents 0.09% of the portfolio and ranks #318 among its holdings.

147 funds tracked by Wall St. Rank hold IMVT as of Q2 2023.

  • EA Series Trust held 136,097 shares of Immunovant worth $2.58M as of Q2 2023.
  • Immunovant was a new EA Series Trust position in Q2 2023.
  • Immunovant made up 0.09% of EA Series Trust's portfolio in Q2 2023, its #318 holding.
  • 147 funds tracked by Wall St. Rank held Immunovant as of Q2 2023.

Based on EA Series Trust's 13F filing for Q2 2023, filed 27 Jul 2023.